e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The biggest challenge we face in PAH today is … To diagnose patients sooner
C.D. Vizza (Rome, Italy)
Source:
Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
Session:
The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
Session type:
Evening Symposium
Number:
1622
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C.D. Vizza (Rome, Italy). The biggest challenge we face in PAH today is … To diagnose patients sooner. Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
The biggest challenge we face in PAH today is … To treat more aggressively
Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
Year: 2011
The biggest challenge we face in PAH today is … To recognise deterioration sooner
Source: Annual Congress 2011 - The 2011 PAH debate: what is the biggest challenge we face to optimise patient outcome?
Year: 2011
How are we going to treat IPF patients in the future?
Source: Annual Congress 2013 –The future of IPF: current mysteries and challenges
Year: 2013
Two major problems in TB patients today: MDR and the abandoned therapy
Source: Annual Congress 2011 - Challenges in tuberculosis control
Year: 2011
Which are the best methods to manage COPD patients in the post-COVID era?
Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era
Year: 2021
How quickly do we identify and treat patients with TB ?
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009
Recognizing patients with sleepapnoea in primary care; a major challenge
Source: International Congress 2018 – Diagnostics including questionnaires
Year: 2018
The challenge of getting the right diagnosis: asthma and COPD, new diagnostic possibilities
Source: International Congress 2016 – Primary Care Day: challenging times I
Year: 2016
How consistently do physicians diagnose and manage drug-induced interstitial lung disease? Two surveys of European ILD specialist physicians
Source: ERJ Open Res, 6 (1) 00286-2019; 10.1183/23120541.00286-2019
Year: 2020
How to manage patients with mild disease in the primary care?
Source: COVID-19 Videos
Year: 2020
TB patients are coming back to hospital – why?
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Recognising advanced disease, advance care planning and recognition of dying for people with COPD
Source: Eur Respir Monogr 2016; 73: 204-220
Year: 2016
The face of COPD in Scotland now and in the future is increasingly female and poor
Source: Eur Respir J 2004; 24: Suppl. 48, 359s
Year: 2004
Should we treat every patient with latent TB? Is there a cost to pay?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions?
Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation
Year: 2019
The burden of meal-related challenges in patients with COPD: Who cares?
Source: International Congress 2019 – Person-centred approaches to COPD and asthma care
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept